Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

被引：87
|
作者：
Jacobson, Caron
Chavez, Julio C.
Sehgal, Alison R.
William, Basem M.
Munoz, Javier
Salles, Gilles
Munshi, Pashna N.
Casulo, Carla
Maloney, David
De Vos, Sven
Reshef, Ran
Leslie, Lori A.
Yakoub-Agha, Ibrahim
Oluwole, Olalekan O.
Fung, Henry C. H.
Rosenblatt, Joseph D.
Rossi, John M.
Goyal, Lovely
Plaks, Vicki
Yang, Yin
Lee, Jennifer
Godfrey, Wayne
Vezan, Remus
Avanzi, Mauro P.
Neelapu, Sattva S.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136834
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma
    Topp, Max
    Van Meerten, Tom
    Houot, Roch
    Minnema, Monique C.
    Milpied, Noel
    Lugtenburg, Pieternella J.
    Thieblemont, Catherine
    Wermke, Martin
    Song, Kevin
    Avivi, Irit
    Kuruvilla, John
    Duhrsen, Ulrich
    Chu, Rachel
    Zheng, Lianqing
    Plaks, Vicki
    Kerber, Anne
    Kersten, Marie Jose'
    BLOOD, 2019, 134
  • [32] ZUMA-11: A Phase 1/2 Multicenter Study of Axicabtagene Ciloleucel (Axi-Cel) plus Utomilumab Patients with Refractory Large B Cell Lymphoma
    Reshef, Ran
    Miklos, David B.
    Timmerman, John M.
    Jacobson, Caron A.
    Bennani, Nabila N.
    Rossi, John M.
    Sherman, Marika
    Zheng, Lianqing
    Sun, Jennifer
    Palluconi, Gabrielle
    Kim, Jenny J.
    Jain, Michael D.
    BLOOD, 2019, 134
  • [33] A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma (CNSL)
    Jacobson, Caron A.
    Falvey, Caroline
    Bouvier, Riemke
    Hogan, Sarah
    Kendricken, Elizabeth
    Jones, Julia
    Grimm, Elizabeth
    Redd, Robert A.
    Lee, Eudocia Q.
    Castro, Luis Gonzalez
    Chukwueke, Ugonma
    Figueroa, Jose McFaline
    Kim, Austin, I
    Torres, Alexandra
    Ramsdell, Linda
    Kean, Leslie S.
    Gerdemann, Ulrike
    Albanese, Alexandre
    Keskula, Paula
    Meredith, David
    Sholl, Lynette
    Poddar, Soumya
    Davis, Madison
    Mao, Daquin
    Filosto, Simone
    Mattie, Mike
    Armand, Philippe
    Nayak, Lakshmi
    BLOOD, 2022, 140 : 1060 - 1061
  • [34] A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL).
    Nayak, Lakshmi
    Chukwueke, Ugonma Nnenna
    Meehan, Christopher
    Redd, Robert
    Hogan, Sarah
    Lee, Eudocia Quant
    Kim, Austin Injae
    Arrillaga-Romany, Isabel
    Figueroa, J. Ricardo Ricardo McFaline
    Castro, Luis Nicolas Gonzalez
    Murakami, Mark Alan
    Huang, Raymond Yi-Kun
    Gerdemann, Ulrike
    Kaminski, James
    Filosto, Simone
    Poddar, Soumya
    Mattie, Mike
    Armand, Philippe
    Kean, Leslie
    Jacobson, Caron Alyce
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Primary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
    Chaganti, Sridhar
    Cwynarski, Kate
    Cunningham, David
    Locke, Frederick L.
    Miklos, David B.
    Jacobson, Caron A.
    Perales, Miguel-Angel
    Kersten, Marie Jose
    Oluwole, Olalekan O.
    Ghobadi, Armin
    Rapoport, Aaron P.
    McGuirk, Joseph P.
    Pagel, John M.
    Munoz, Javier
    Farooq, Umar
    van Meerten, Tom
    Reagan, Patrick M.
    Sureda, Anna
    Flinn, Ian W.
    Vandenberghe, Peter
    Song, Kevin W.
    Dickinson, Michael
    Minnema, Monique C.
    Riedell, Peter A.
    Leslie, Lori A.
    Yang, Yin
    Filosto, Simone
    Schupp, Marco
    To, Christina
    Cheng, Paul
    Gordon, Leo I.
    Radford, John
    Westin, Jason R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 20 - 22
  • [36] AN UPDATED TWO-YEAR SURVIVAL ANALYSIS OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (R/R-LBCL)
    Diakite, I
    Lin, V. W.
    Klijn, S.
    Navale, L.
    Purdum, A. G.
    Fenwick, E.
    Botteman, M.
    van Hout, B.
    VALUE IN HEALTH, 2019, 22 : S41 - S41
  • [37] Budget Impact Model of Axicabtagene Ciloleucel (Axi-cel) in a US Population of Patients with Relapsed or Refractory Large B-Cell Lymphoma (R/R-LBCL)
    Hathway, Joanne
    Purdum, Anna
    Lin, Vincent W.
    Cyr, Philip
    Westin, Jason
    Jensen, Ivar
    BONE MARROW TRANSPLANTATION, 2018, 53 : 878 - 879
  • [38] Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
    Ghione, Paola
    Palomba, M. Lia
    Patel, Anik R.
    Bobillo, Sabela
    Deighton, Kevin
    Jacobson, Caron A.
    Nahas, Myrna
    Hatswell, Anthony J.
    Jung, A. Scott
    Kanters, Steve
    Snider, Julia Thornton
    Neelapu, Sattva S.
    Ribeiro, Maria Teresa
    Brookhart, M. Alan
    Ghesquieres, Herve
    Radford, John
    Gribben, John G.
    BLOOD, 2022, 140 (08) : 851 - 860
  • [39] ZUMA-7: A phase 3 randomized trial of axicabtagene ciloleucel (Axi-Cel) versus standard-of-care (SOC) therapy in patients with relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL).
    Oluwole, Olalekan O.
    Bishop, Michael Russell
    Gisselbrecht, Christian
    Gordon, Leo I.
    Kersten, Marie Jose
    Maloney, David G.
    Schmitz, Norbert
    Barrigon, Maria Dolores Caballero
    Kuruvilla, John
    Song, Kevin W.
    Jacobson, Caron A.
    Nastoupil, Loretta J.
    Riedell, Peter
    Jiang, Yizhou
    Rossi, John M.
    Lee, Lillian
    Cheng, Paul C.
    Locke, Frederick Lundry
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] A PILOT STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSED/REFRACTORY PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL AND SCNSL)
    Nayak, Lakshmi
    Falvey, Caroline
    Bouvier, Riemke
    Chukwueke, Ugonma
    Hogan, Sarah
    Kendricken, Elizabeth
    Meehan, Christopher
    Redd, Robert
    Fisher, Jennifer
    Torres, Alexandra
    Jones, Julia
    Lee, Eudocia
    Kim, Austin
    Castro, Luis Nicolas Gonzalez
    McFaline-Figueroa, Jose Ricardo
    Aquilanti, Elisa
    Youssef, Gilbert
    Arrillaga-Romany, Isabel
    Murakami, Mark
    Sholl, Lynette
    Meredith, David
    Huang, Raymond Y.
    Ramsdell, Linda
    Gerdemann, Ulrike
    Keskula, Paula
    Kaminski, Jim
    Albanese, Alexandre
    Bi, Wenya Linda
    Arnaout, Omar
    Reardon, David
    Wen, Patrick
    Poddar, Soumya
    Mao, Daqin
    Mattie, Mike
    Davis, Madison
    Filosto, Simone
    Kean, Leslie
    Armand, Philippe
    Jacobson, Caron
    NEURO-ONCOLOGY, 2023, 25
12345